Sociedad Química y Minera de Chile (SQM) Corporate Presentation summary

Financial performance and business mix

• Last twelve months revenues reached $4.5 billion, with adjusted EBITDA of $1.4 billion and a 32% margin; net financial debt to EBITDA at 1.6x as of March 2025.

• Q1 2025 revenue was $1,037 million, adjusted EBITDA $360 million (35% margin), and net income $138 million; earnings per share at $0.48.

• Lithium and derivatives contributed 49% of revenues, specialty plant nutrition 21%, iodine 22%, potassium 6%, and industrial chemicals 2%.

• Q1 2025 saw a 3.5% revenue decline year-on-year, with gross profit down 17% and adjusted EBITDA down 11%.

• Dividend policy distributes 30% of net income; ownership is diversified among ADR holders, Tianqi, Pampa Group, Kowa Group, Chilean pension funds, and others.

Business segment highlights

• Lithium sales volumes grew 27% year-on-year in Q1 2025, but average prices fell 27%; segment gross profit was $517 million on $2,197 million revenues.

• Iodine and derivatives saw a 10% increase in average prices, with gross profit of $525 million and revenues of $983 million; market share estimated at 37%.

• Specialty plant nutrition gross profit was $161 million on $946 million revenues, with a 41% global market share and expected 4-5% market growth in 2025.

• Potassium segment gross profit was $33 million on $250 million revenues; sales volumes expected to decline by 50% in 2025.

• Industrial chemicals gross profit was $30 million on $75 million revenues, with a stable outlook and 32% market share in industrial potassium nitrate.

Strategic initiatives and sustainability

• Sustainability is a core value, with participation in UN Global Compact, Global Battery Alliance, DJSI, IRMA, CDP, SBTI, and other ESG initiatives.

• Business strategy emphasizes responsible processes, sustainable supply chain, innovation, and human development.

• Ongoing R&D and capacity expansions in lithium (Chile, Australia, China) and iodine/nitrates (brownfield and greenfield projects) support future growth.

• 2025 capex planned at $750 million for lithium and $350 million for iodine/nitrates, including maintenance.

• Agreement with CORFO includes production quotas, lease fees, and annual contributions to R&D and local communities.